Adverse drug events in surgical patients: An observational multicentre study

International Journal of Clinical Pharmacy

Volumn 35, Issue 5, 2013, Pages 744-752

  De Boer, Monica ^a   Boeker, Eveline B ^a   Ramrattan, Maya A ^a,b   Kiewiet, Jordy J S ^a   Dijkgraaf, Marcel G W ^a   Boermeester, Marja A ^a   Lie A Huen, Loraine ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Maasstad Hospital   (Netherlands)

Author keywords

Adverse drug events; Incidence; Preventability; Risk factors; Surgical patient; The Netherlands

Indexed keywords

ANTICOAGULANT AGENT; OPIATE;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; COMPUTERIZED PROVIDER ORDER ENTRY; DECISION SUPPORT SYSTEM; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL SURGERY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SURGICAL PATIENT; SURGICAL WARD; VASCULAR SURGERY;

AGED; ANALGESICS, OPIOID; ANTICOAGULANTS; COHORT STUDIES; DRUG MONITORING; DRUG THERAPY, COMPUTER-ASSISTED; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NETHERLANDS; PHARMACY SERVICE, HOSPITAL; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURGERY DEPARTMENT, HOSPITAL; SURGICAL PROCEDURES, ELECTIVE; VASCULAR SURGICAL PROCEDURES;

EID: 84886026484     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-013-9797-5     Document Type: Article

References (18)

1. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324(6):377-84.
2. Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care. 2004;13(4):306-14.
3. Cano FG, Rozenfeld S. Adverse drug events in hospitals: a systematic review. Cad saude publica. 2009;25(3):360-72.
4. Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm. 2003;60(17):1750-9.
5. de Vries EN, Ramrattan MA, Smorenburg SM, Gouma DJ, Boermeester MA. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care. 2008;17(3):216-23.
6. Bates DW, Miller EB, Cullen DJ, Burdick L, Williams L, Laird N, et al. Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med. 1999;159(21):2553-60.
7. de Vries EN, Prins HA, Crolla RMPH, den Outer AJ, van Andel G, van Helden SH, et al. Effect of a comprehensive surgical safety system on patient outcomes. N Engl J Med. 2010;363(20):1928-37.
8. Lazarus HM, Fox J, Evans RS, Lloyd JF, Pombo DJ, Burke JP, et al. Adverse drug events in trauma patients. J Trauma. 2003;54(2):337-43.
9. Morimoto T, Sakuma M, Matsui K, Kuramoto N, Toshiro J, Murakami J, et al. Incidence of adverse drug events and medication errors in Japan: the JADE study. J Gen Inter Med. 2011;26(2):148-53.
10. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274(1):29-34.
11. Berga C, Gorgas Torner M, Altimiras R, Tuset CM, Besalduch MM, Capdevilla SM, et al. Detecting adverse drug events during hospital stay. Farm Hosp. 2009;33(6):312-23.
12. Nebeker JR, Hoffman JM, Weir CR, Bennet CL, Hurdle JF. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med. 2005;165(10):1111-6.
13. de Boer M, Kiewiet JJS, Boeker EB, Ramrattan MA, Dijkgraaf MGW, Lie-A-Huen L, et al. A targeted method for standardized assessment of adverse drug events in surgical patients. J Eval Clin Pract 2013 [Epub ahead of print].
14. Euroqol (EQ). EQ-5D. Available at: http://www.euroqol.org/. Accessed 2010.
15. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical classification system. Available at: http://www.whocc.no/. Accessed 2012.
16. Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997;25(8):1289-97.
17. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v4.0. Available at: http://www.cancer.gov/. Accessed 2010.
18. de Boer M, Ramrattan MA, Kiewiet JJ, Boeker EB, Gombert-Handoko KB, van Lent-Evers NAEM, et al. Cost-effectiveness of ward-based pharmacy care in surgical patients: protocol of the SUREPILL (Surgery & Pharmacy In Liaison) study. BMC Health Serv Res. 2011;11(1):55.